Osteoporosis is a condition where bones become porous and fragile, greatly increasing fracture risk. It is often called a 'silent disease' because bone loss occurs without symptoms until a fracture happens, most commonly in the hip, spine, or wrist.
Alendronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat and prevent osteoporosis and other metabolic bone diseases.
Risedronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat and prevent osteoporosis and other metabolic bone diseases.
Ibandronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat and prevent osteoporosis and other metabolic bone diseases.
Zoledronic Acid is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat and prevent osteoporosis and other metabolic bone diseases.
Raloxifene is a selective estrogen receptor modulator (SERM) used to prevent and treat osteoporosis in postmenopausal women.
Denosumab is a RANK ligand inhibitor that prevents bone loss and is used to treat osteoporosis and bone metastases.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: